Is the War on Drugs a Failure? What the Evidence Shows After Decades
The War on Drugs can be assessed empirically. It had stated goals. Those goals can be measured. The data on drug use rates, incarceration rates, drug-related crime, and public health outcomes over the decades of the drug war's operation are available from federal agencies, academic researchers, and international organizations. The conclusion they support is not a political judgment — it is a measurement.
This guide applies the tier system to the drug war evidence: what is confirmed, what is strongly suggested, and where the Tier 3 claim — that consciousness suppression was a deliberate goal — enters the picture.
The Ehrlichman Admission
This is Tier 1. It is not contested. John Ehrlichman, Nixon's chief domestic adviser, gave the following statement to journalist Dan Baum in an interview shortly before his death. It was published in Harper's Magazine and has been widely confirmed:
"The Nixon campaign in 1968, and the Nixon White House after that, had two enemies: the antiwar left and Black people... We knew we couldn't make it illegal to be either against the war or Black, but by getting the public to associate the hippies with marijuana and Blacks with heroin, and then criminalizing both heavily, we could disrupt those communities. We could arrest their leaders, raid their homes, break up their meetings, and vilify them night after night on the evening news."
This is a first-person admission by a senior official that the War on Drugs was not primarily a public health initiative. It was a political strategy targeting specific communities for reasons unrelated to pharmacology. This does not prove the entire drug war was designed as consciousness suppression — but it establishes that the policy's stated rationale was not its actual rationale, at least at its origin.
The Goals vs Outcomes Assessment
| Stated Goal | Measurement | Outcome | Tier |
|---|---|---|---|
| Reduce drug use | Prevalence surveys; DEA drug availability data | Drug use rates roughly stable or increasing over 50 years; drug availability increased | Tier 1 — goal not achieved |
| Reduce drug-related crime | FBI crime statistics; drug market violence data | Drug prohibition created profitable black markets; drug war-related violence endemic; incarceration rates rose dramatically | Tier 1 — prohibition created the crime it claimed to address |
| Reduce drug trafficking | DEA seizure data; drug availability pricing | Drug prices fell and availability increased over the drug war's duration — opposite of interdiction success | Tier 1 — goal not achieved |
| Protect public health | Drug overdose deaths; treatment access; HIV transmission rates | Overdose deaths at historic highs; prohibition impeded harm reduction; criminalization reduced treatment seeking | Tier 1 — public health worsened |
| International: export drug prohibition model | UN drug policy data; global drug use rates | Global drug use did not decline; countries that deviated (Portugal) showed better outcomes | Tier 1 — model failed internationally |
The Portugal Evidence
Portugal decriminalized possession of all drugs — not just cannabis — in 2001. The model: possession remains a legal violation but is treated as a health issue rather than a criminal one. Treatment is funded and accessible. Trafficking remains illegal.
Results over two decades:
- Drug use did not surge following decriminalization (it slightly declined)
- Drug-related HIV infections fell by approximately 75 percent
- Drug-related incarceration fell dramatically
- Treatment uptake increased substantially
- Drug-related deaths declined
Portugal's outcomes do not prove that legalization universally produces better outcomes — the policy is decriminalization with investment in treatment, not simply removing legal prohibition. But they provide a rigorous natural experiment that directly contradicts the central claim of drug prohibition: that criminalization is necessary to prevent drug use and its harms.
The Portugal experiment is the most important single data point in drug policy. It directly tested the premise of the drug war — that criminalization reduces use and harm — under real conditions with real populations. The result contradicted the premise across every measured outcome. This is Tier 1 evidence that the drug war's model is wrong.
The Schedule I Research Blockade
One of the drug war's most specific and measurable harms is the research blockade. Schedule I classification requires not just criminal penalties for use — it creates bureaucratic barriers to scientific research so significant that legitimate clinical study of Schedule I compounds was essentially halted for decades.
Psilocybin, MDMA, LSD, and other Schedule I psychedelics showed therapeutic promise in pre-prohibition research. That research was stopped, not by evidence of harm, but by scheduling that preceded systematic safety evidence. The current psychedelic renaissance represents researchers fighting to overcome those barriers, often spending years on regulatory approval processes before conducting a single trial.
What was lost: decades of research that could have developed therapeutic applications for the millions of people who suffer from treatment-resistant depression, PTSD, addiction, and end-of-life anxiety. The cost in human suffering of that research gap is incalculable but real.
The Tier 3 Claim
Tier 3: The drug war was designed in part to suppress access to consciousness-expanding compounds specifically, because their potential for catalyzing political consciousness was understood.
This interpretation is supported by: Ehrlichman's admission connecting the drug war's origin to political suppression of specific communities; the historical timing of LSD criminalization at the peak of the counterculture; the conspicuous severity of psychedelic scheduling (Schedule I, same as heroin) relative to pharmacological evidence of harm; and the specific obstruction of psychedelic research rather than other Schedule I drugs.
It is not supported by: direct evidence that any decision-maker explicitly articulated a goal of suppressing consciousness-expanding properties specifically (the Ehrlichman admission addresses political suppression of communities, not consciousness suppression per se).
The Technospermia interpretation — that suppressing psychedelic access was specifically aimed at keeping humans from the consciousness-expanding technology seeded into the biosphere — is Tier 3 within the Tier 3. It is a coherent extension of the deliberate suppression hypothesis but requires additional inference beyond the available evidence.
The Technospermia Lens
Technospermia: The Suppression of Consciousness Technology
If psychedelic compounds are deliberate biological technology for consciousness expansion, then their suppression has measurable costs — not just in human suffering from untreated PTSD and addiction, but in the delay of the consciousness development the seeding was designed to catalyze. The drug war's specific targeting of psychedelics — at severity inconsistent with pharmacological harm profiles — is consistent with either political accident or deliberate suppression. Whether the suppression was intentional, opportunistic, or incidental to political goals is the Tier 3 question.
The Technospermia theory places psychedelic compounds at the center of a deliberate consciousness-expanding project. The War on Drugs, whatever its intentions, functionally suppressed access to that project for decades. The Ehrlichman admission confirms that political rather than pharmacological logic drove the initial criminalization. The Schedule I research blockade confirms that the suppression extended to scientific investigation.
Whether the suppression was deliberate consciousness management or opportunistic political weaponization is genuinely uncertain. What is Tier 1 is the outcome: the compounds with the strongest consciousness-expanding properties received the most severe legal classification, despite evidence profiles that did not warrant it.
Continue reading: Was the Drug War Designed to Suppress Psychedelics? · Government Suppressing Psychedelics — The Evidence
Share this transmission